HHMI
PGEN icon

Howard Hughes Medical Institute’s Precigen PGEN Stock Holding History

Howard Hughes Medical Institute’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-793
Closed -$21K – 186
2014
Q4 		$21K Sell
793
-176
-18% -$3.86K 0.01% 161
2014
Q3 		$17K Sell
969
-911
-48% -$18.6K ﹤0.01% 171
2014
Q2 		$45K Sell
1,880
-720
-28% -$14.6K 0.01% 147
2014
Q1 		$65K Sell
2,600
-135
-5% -$3.74K 0.01% 143
2013
Q4 		$62K Buy
+2,735
New +$55.3K 0.01% 154

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Howard Hughes Medical Institute's PGEN Position: Q1 2015 in Review

Howard Hughes Medical Institute sold out of Precigen (PGEN) in Q1 2015, closing a stake of 793 shares — an estimated $21K sold.

Howard Hughes Medical Institute first reported a position in PGEN in Q4 2013 and held it in 5 quarters. The position peaked at $65K in Q1 2014. 154 funds tracked by Wall St. Rank hold PGEN as of Q1 2015.

  • Howard Hughes Medical Institute reported no remaining Precigen position as of Q1 2015 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 793 Precigen shares in Q1 2015, an estimated $21K.
  • Howard Hughes Medical Institute first reported a position in Precigen in Q4 2013 and held it in 5 quarters.
  • Howard Hughes Medical Institute's Precigen position peaked at $65K in Q1 2014.
  • 154 funds tracked by Wall St. Rank held Precigen as of Q1 2015.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2015, filed 14 May 2015.